进行性核上性麻痹与皮质基底节综合征等4重复tau蛋白病中的tau显像:11C-吡啶基-丁二烯基-苯并噻唑3 PET初步研究
回顾性分析2例皮质基底节综合征、7例进行性核上性麻痹和2例阿尔茨海默痴呆患者的11C-PBB3 PET,比较诊断组间摄取差异。结果显示皮质基底节综合征患者背外侧额叶和运动皮质摄取显著高于进行性核上性麻痹患者,阿尔茨海默痴呆患者额叶和颞叶皮质摄取显著高于进行性核上性麻痹患者;进行性核上性麻痹患者中脑摄取较阿尔茨海默痴呆患者轻度但显著升高。作者认为11C-PBB3 tau结合的空间模式和幅度在三种疾病间存在差异,可能具有诊断价值。
要点
- 皮质基底节综合征患者背外侧额叶和运动皮质11C-PBB3摄取显著高于进行性核上性麻痹患者。
- 阿尔茨海默痴呆患者额叶和颞叶皮质11C-PBB3摄取显著高于进行性核上性麻痹患者。
- 进行性核上性麻痹患者中脑11C-PBB3摄取较阿尔茨海默痴呆患者轻度但显著升高。
核心结论
- 11C-PBB3 tau结合的空间模式和幅度在皮质基底节综合征、进行性核上性麻痹和阿尔茨海默痴呆之间存在差异,与已知神经病理改变一致,可能具有诊断价值。
- 11C-PBB3为包括4重复tau蛋白病在内的tau显像配体开发提供了有前景的先导结构。
研究设计与样本
- 回顾性分析11C-PBB3 PET在皮质基底节综合征2例、进行性核上性麻痹7例和阿尔茨海默痴呆2例患者中的表现。
主要发现
- 与进行性核上性麻痹患者相比,皮质基底节综合征患者背外侧额叶和运动皮质11C-PBB3摄取显著更高。
- 与进行性核上性麻痹患者相比,阿尔茨海默痴呆患者额叶和颞叶皮质11C-PBB3摄取显著更高。
- 与阿尔茨海默痴呆患者相比,进行性核上性麻痹患者中脑11C-PBB3摄取轻度但显著更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To evaluate tau PET using C-pyridinyl-butadienyl-benzothiazole 3 (C-PBB3) in the 4-repeat (4R)-tauopathies progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). METHODS: Retrospective analysis of C-PBB3 PET in 2, 7, and 2 patients with CBS, PSP, and Alzheimer dementia (AD), respectively. Normalized C-PBB3 uptake in clusters with significant hypometabolism on F-FDG-PET and corresponding atlas-based volumes of interest was compared between diagnostic groups. RESULTS: In accordance with visually appreciable group differences, C-PBB3 uptake was significantly higher in dorsolateral frontal and motor cortex in CBS patients and frontal and temporal cortices in AD patients as compared with PSP patients. Patients with PSP showed mildly but significantly higher uptake in midbrain compared with AD patients. CONCLUSIONS: In line with known neuropathological changes, the spatial pattern and magnitude of C-PBB3 tau binding differ between CBS, PSP, and AD, which may be of diagnostic utility. Thus, C-PBB3 offers a promising lead structure for development of ligands for tau imaging, including 4R-tauopathies.
引用
- Schröter N, Blazhenets G, Frings L, et al. Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study. Clin Nucl Med. 2020. PMID: 32108694. doi:10.1097/RLU.0000000000002949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。